12459371

Source:http://linkedlifedata.com/resource/pubmed/id/12459371

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0023434, umls-concept:C0205221, umls-concept:C0205276, umls-concept:C0282460, umls-concept:C1285530, umls-concept:C1334170, umls-concept:C1522449
pubmed:dateCreated	2002-12-2
pubmed:abstractText	Indolent non-Hodgkin's lymphoma (INHL) and chronic lymphocytic leukemia (CLL) are highly sensitive to radiotherapy (RT). Previous retrospective studies have shown high response rates after local palliative RT of 4 Gy in 2 fractions, which prompted this prospective Phase II trial of the palliative effect of this regimen in patients with disseminated INHL or CLL.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/12459371-12829161
pubmed:language	eng
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:author	pubmed-author:JóhannssonJakobJ, pubmed-author:JensenBjarne AnkerBA, pubmed-author:MejerJohannesJ, pubmed-author:SpechtLenaL
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1466-70
pubmed:dateRevised	2007-11-15
pubmed:articleTitle	Phase II study of palliative low-dose local radiotherapy in disseminated indolent non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
pubmed:affiliation	Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.